Filip Janku, M.D., Ph.D., is a medical oncologist and clinical researcher at MD Anderson Cancer Center. His work focuses on early-phase cancer therapeutics, molecularly targeted treatments, and liquid-biopsy approaches for tracking tumor genetics and treatment response.
Filip Janku, M.D., Ph.D., is a medical oncologist and clinical researcher at MD Anderson Cancer Center. His work focuses on early-phase cancer therapeutics, molecularly targeted treatments, and liquid-biopsy approaches for tracking tumor genetics and treatment response.